Personal information | |
---|---|
Born | Franschhoek, South Africa | 23 April 1985
Team information | |
Current team | Team Enza |
Disciplines |
|
Role | Rider |
Rider type | Sprinter |
Amateur teams | |
2014–2015 | Team Abantu |
2016 | Telkom |
2017–2018 | BCX |
2019– | Team Enza |
Professional teams | |
2005 | Team Exel |
2008–2009 | Team Neotel |
2019 | Team VanderGroup |
Nolan Hoffman (born 23 April 1985) is a South African road and track cyclist, who currently rides for South African team Enza. He was suspended for eighteen months after he tested positive for the use of testosterone on 18 October 2009.[1] He competed in the scratch event at the UCI Track Cycling World Championships in 2012, 2013 and 2014, winning the silver medal in 2012.[2]
Major results
- 2005
- 1st Stage 3 (TTT) Tour d'Egypte
- 2007
- 5th Road race, African Road Championships
- 2008
- 1st Powerade Dome 2 Dome Cycling Spectacular
- 4th Overall Tour de Korea
- 1st Stage 9
- 2009
- 1st Stage 1 Tour de Korea
- 3rd Giro del Capo IV
- 2011
- All-Africa Games
- 1st Road race
- 1st Team time trial (with Jay Thomson, Reinardt Janse van Rensburg and Darren Lill)
- 2012
- 2nd Scratch, UCI Track Cycling World Championships
- 2014
- 1st Cape Town Cycle Tour
- 1st Points classification Mzansi Tour
- 2015
- 1st Cape Town Cycle Tour
- KZN Autumn Series
- 8th Mayday Classic
- 10th PMB Road Classic
- 2018
- 1st 100 Cycle Challenge
- 1st Cape Town Cycle Tour
- 3rd Road race, National Road Championships
- 2019
- Tour of Good Hope
- 1st Points classification
- 1st Stage 1
- 3rd 100 Cycle Challenge
- 2021
- 1st Cape Town Cycle Tour
References
- ↑ Sébastien Barbay (8 January 2010). "Hoffman positif, Neotel se retire" (in French). cyclismactu.net. Retrieved 5 May 2015.
- ↑ "2014 Track Cycling World Championships: Entries list". tissottiming.com. Retrieved 1 February 2016.
External links
- Nolan Hoffman at UCI
- Nolan Hoffman at Cycling Archives
- Nolan Hoffman at ProCyclingStats
- Nolan Hoffman at Cycling Quotient
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.